MDUFMA device branding on hold
This article was originally published in The Gray Sheet
Executive Summary
Draft guidance entitled "1Compliance with Sec. 301 of the Medical Device User Fee & Modernization Act of 2002 - Identification of Manufacturer of Medical Devices" announcing FDA plans to exercise enforcement discretion and "not...object if a manufacturer has not fully implemented the changes required by Sec. 301" is posted June 19. The guidance, which includes a FAQ section affirms previous statements from staff conveying FDA's intent to give manufacturers an 18-month grace period to implement the MDUFMA provision once FDA issues final guidance on how to comply with Sec. 301 (2"The Gray Sheet" June 9, 2003, p. 9). MDUFMA Sec. 302, which requires reprocessors to label single-use devices with the reprocessor name, is outside the scope of the guidance and will be detailed in a separate guidance, FDA notes...
You may also be interested in...
Sec. 301 branding provisions on chopping block?
Oct. 29, the Senate HELP Committee's last scheduled mark-up date, may provide OEMs with their final opportunity this year to secure technical corrections to MDUFMA clarifying that inclusion of a manufacturer's name, abbreviation or symbol should apply only to single-use device reprocessors, not to OEMs. Without the legislative fix, advocated in several industry comments to FDA, the agency will be hard pressed to develop branding guidance, according to CDRH staffers. In June, FDA released a 1draft guidance indicating an 18-month grace period would be attached to the final guidance release date (2"The Gray Sheet" June 23, 2003, In Brief)...
MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance
FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.